Suppr超能文献

含维生素K的膳食补充剂:合成维生素K1与纳豆衍生的甲萘醌-7的比较

Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.

作者信息

Schurgers Leon J, Teunissen Kirsten J F, Hamulyák Karly, Knapen Marjo H J, Vik Hogne, Vermeer Cees

机构信息

VitaK & Cardiovascular Research Institute Maastricht, University of Maastricht, 6200 MD Maastricht, The Netherlands.

出版信息

Blood. 2007 Apr 15;109(8):3279-83. doi: 10.1182/blood-2006-08-040709. Epub 2006 Dec 7.

Abstract

Vitamin K is a cofactor in the production of blood coagulation factors (in the liver), osteocalcin (in bone), and matrix Gla protein (cartilage and vessel wall). Accumulating evidence suggests that for optimal bone and vascular health, relatively high intakes of vitamin K are required. The synthetic short-chain vitamin K(1) is commonly used in food supplements, but recently the natural long-chain menaquinone-7 (MK-7) has also become available as an over-the-counter (OTC) supplement. The purpose of this paper was to compare in healthy volunteers the absorption and efficacy of K(1) and MK-7. Serum vitamin K species were used as a marker for absorption and osteocalcin carboxylation as a marker for activity. Both K(1) and MK-7 were absorbed well, with peak serum concentrations at 4 hours after intake. A major difference between the 2 vitamin K species is the very long half-life time of MK-7, resulting in much more stable serum levels, and accumulation of MK-7 to higher levels (7- to 8-fold) during prolonged intake. MK-7 induced more complete carboxylation of osteocalcin, and hematologists should be aware that preparations supplying 50 mug/d or more of MK-7 may interfere with oral anticoagulant treatment in a clinically relevant way.

摘要

维生素K是血液凝固因子(在肝脏中)、骨钙素(在骨骼中)和基质Gla蛋白(软骨和血管壁)生成过程中的一种辅助因子。越来越多的证据表明,为了骨骼和血管的最佳健康状态,需要相对较高的维生素K摄入量。合成的短链维生素K(1)常用于食品补充剂,但最近天然的长链甲萘醌-7(MK-7)也已作为非处方药(OTC)补充剂上市。本文的目的是在健康志愿者中比较K(1)和MK-7的吸收情况和功效。血清维生素K种类用作吸收的标志物,骨钙素羧化用作活性的标志物。K(1)和MK-7的吸收都很好,摄入后4小时血清浓度达到峰值。这两种维生素K种类之间的一个主要区别是MK-7的半衰期非常长,导致血清水平更稳定,并且在长期摄入期间MK-7会积累到更高水平(7至8倍)。MK-7诱导骨钙素更完全的羧化,血液学家应该意识到,每天提供50微克或更多MK-7的制剂可能会以临床相关的方式干扰口服抗凝治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验